Lactobacillus rhamnosus Lr-32 and Reduced Tumor Growth

• Oncolytic Probiotics with Molecular Pili for Solid Tumor Therapy.

  • 2026-02-03
  • Advanced science (Weinheim, Baden-Wurttemberg, Germany) 13(19)
  • • Haodong Ge
    • Chengsheng Ding
    • Xiao Yang
    • Si Gao
    • Changjie Yang
    • Yuchen Hou
    • Hongye Wang
    • Linke Bian
    • Hao Zhong
    • Yifan Qu
    • Luyang Zhang
    • Junjun Ma
    • Zhengwei Cai
    • Wenguo Cui
    • Minhua Zheng

  • PubMed: 41632211
  • DOI: 10.1002/advs.202517989

  2 Insights on

  • Reduced Tumor Growth

  • Low evidence

  At a safe dose of 4 × 10⁵ CFU, LR@MP inhibited 60%-80% of tumor growth.

  Effect

  Beneficial

  Effect size

  Large